FDA Works to Improve ANDA Processes Ahead of Fall Deadline

Generic Line
SAN DIEGO — The FDA is racing to beat a fall deadline to release a string of new guidances for generics makers that it hopes will head off a potential torrent of rejected submissions.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00